Programmed death ligand I expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+)T-cell immune responses | |
Zhu, Ying; Wang, Xiang-Yu; Zhang, Yu; Xu, Da; Dong, Jian; Zhang, Ze; Yi, Chen-He; Jia, Hu-Liang; Yang, Xin | |
刊名 | CANCER MANAGEMENT AND RESEARCH
![]() |
2018 | |
卷号 | 10 |
关键词 | tumor microenvironment adaptive immune resistance PD-L1 CD8(+)T-cell IFN-gamma |
ISSN号 | 1179-1322 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3609200 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhu, Ying,Wang, Xiang-Yu,Zhang, Yu,et al. Programmed death ligand I expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+)T-cell immune responses[J]. CANCER MANAGEMENT AND RESEARCH,2018,10. |
APA | Zhu, Ying.,Wang, Xiang-Yu.,Zhang, Yu.,Xu, Da.,Dong, Jian.,...&Yang, Xin.(2018).Programmed death ligand I expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+)T-cell immune responses.CANCER MANAGEMENT AND RESEARCH,10. |
MLA | Zhu, Ying,et al."Programmed death ligand I expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+)T-cell immune responses".CANCER MANAGEMENT AND RESEARCH 10(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论